The drug was developed with help from the U.S. National Institute of Drug Abuse, and showed promise in early studies, however, two successive phase III trials of the drug in 2009 and 2011 failed.
The drug was developed with help from the U.S. National Institute of Drug Abuse, and showed promise in early studies, two successive phase III trials of the drug in 2009 and 2011 failed. This was however.